Showing results (211-220 of 339) with videos related to
Sort By:
Pageof 34
The Pediatric Infectious Disease Journal|September 17, 2015
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013Tina Tan, Tine Dalby, Kevin Forsyth, et al.Human Vaccines & Immunotherapeutics|January 6, 2026
Healthcare providers' awareness, attitudes, beliefs, and practices surrounding pharmacist-administered vaccination: Insights after a two-year interventionAntonia M Di Castri, Donna M Halperin, Jennifer E Isenor, et al.Infection|November 6, 2023
Antibiotic use in children hospitalised for influenza, 2010-2021: the Canadian Immunization Monitoring Program Active (IMPACT)Tilmann Schober, Shaun K Morris, Julie A Bettinger, et al.Journal of Clinical Microbiology|August 19, 2007
Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresisHans Hallander, Abdolreza Advani, Marion Riffelmann, et al.Vaccine|February 3, 2007
Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adultsShelly A McNeil, Francisco Noya, Marc Dionne, et al.The Journal of Infectious Diseases|October 4, 2016
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum AdjuvantJoanne M Langley, Naresh Aggarwal, Azhar Toma, et al.Vaccine|December 23, 2023
An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) studyJoanne M Langley, Soren Gantt, Scott A Halperin, et al.Vaccine|January 28, 2020
Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp)Julie A Bettinger, Paul Liberator, Scott A Halperin, et al.BMC Public Health|December 6, 2025
The impact of two-year community-wide pharmacy interventions on the public's knowledge, attitudes, beliefs and behaviors about pharmacists as immunizersDonna M Halperin, Antonia M Di Castri, Jennifer E Isenor, et al.Human Vaccines & Immunotherapeutics|April 11, 2013
Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccineScott A Halperin, Brian J Ward, Marc Dionne, et al.Pageof 34